AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02978768 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: First year, the investigators investigate the effect of 12-week Tai Chi 6-Form accompanied with music rhythm for patients with mild and moderate AD in behavioral and general health, functional and cognitive decline.
Study NCT02978768 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training
Description: Second year, the investigators investigate the effect of 12-week computer-based cognitive training games for patients with mild and moderate AD in behavioral and general health, functional and cognitive decline.
Study NCT03728361 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT03728361 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given PO
Study NCT02951598 — intervention group
Intervention type: DRUG
Intervention: Florbetapir F 18 PET Scan
Description: Florbetapir F 18 positron emission tomography (PET) scan performed at baseline to confirm amyloid status. Participants who previously tested amyloid positive were exempt. No therapeutic investigational drug(s) intended to treat AD will be administered.
Study NCT01674764 — intervention group
Intervention type: PROCEDURE
Intervention: Early surgical intervention
Description: Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation
Study NCT01674764 — intervention group
Intervention type: PROCEDURE
Intervention: Late surgical intervention
Description: Open surgical stabilization and decompression (anterior, posterior or circumferential); and/or Closed reduction and external fixation
Study NCT04652362 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Growth Mindset Online Single-Session Intervention
Description: During the self-administered single session intervention participants are provided with basic information about the brain and are introduced to the concept of neuroplasticity. The concept of neuroplasticity is applied to personal traits, such as shyness, anxiety and sadness, and young people are taught that these traits are the result of thoughts and feelings in our brain and are amenable to change. Participants are presented with scientific information and research evidence to support the idea that people have the potential to change and are given vignettes from older children detailing how they have used a growth mindset to overcome difficulties. The intervention takes approximately 20-30 minutes to complete.
Study NCT04652362 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supportive Therapy Online Single-Session Intervention (Control)
Description: The single session supportive therapy intervention was designed to be structurally comparable to the growth mindset intervention, including the same number of reading and writing activities. Participants were provided with information about emotions and the benefits of expressing emotions. Vignettes from older children described times they had shared their emotions with friends and family members.
Study NCT03830138 — intervention group
Intervention type: GENETIC
Intervention: Oxidized-LDL gene polymorphism
Description: Oxidized-LDL gene polymorphism will be measured by RFLP. In addition, Oxidized-LDL will be measured in the plasma by ELISA
Study NCT01936246 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Increased protein
Study NCT06170255 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Description: Behavioral activation involves an exploration of the patient's individualized values and follows with goal setting to improve depression symptoms.
Study NCT02978768 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Physico-Mental rehabilitation Wii
Description: Third year, the investigators investigate the effect of 12-week Physico-Mental rehabilitation Wii (PM Wii) for patients with mild and moderate AD in behavioral and general health, functional and cognitive decline.
Study NCT04488094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [18F]FSPG
Description: A radioactive dose of 200 MBq of the study drug with a total quantity of ≤ 100 µg will be administered as slow intravenous bolus injection over up to 60 seconds. PET/CT examinations will be performed at 60-75 min after the administration of \[18F\]FSPG.
Study NCT00291226 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glycine
Description: Glycine 0.4 g/kg bid
Study NCT00291226 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02801773 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Treatment Gingivitis with Probiotic
Description: Gingivitis Treatment (scaling and coronary polish) and one lozenge containing Lactobacillus reuteri per day during 3 months
Study NCT02801773 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Treatment Gingivitis conventional
Description: gingivis treatment (scaling and coronary polish) and and one lozenge containing Placebo (mint lozenge) per day during 3 months
Study NCT03432962 — intervention group
Intervention type: OTHER
Intervention: no intervention - recoding of food recall only
Description: recoding of food recall
Study NCT01280500 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: electronic medical record
Description: Decision Support, Asthma Action Plans, and Population Management Reporting (EAP)
Study NCT01280500 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Integrated Approach to Care
Description: Patients within the IAC group will also receive their own copy of an asthma action plan to allow for some degree of self-management support. In addition, IAC practices receive assistance from a practice coach trained in practice redesign and rapid cycle process improvement.
Study NCT01280500 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: usual care
Description: No EMR
Study NCT01280500 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Shared Decision Making
Description: The research team will develop the SDM intervention during the first 6 months of the study. The team will model this intervention on the randomized control trial performed by Dr. Sandra Wilson and colleagues within the Kaiser Permanente Clinics in California and Oregon
Study NCT01280500 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: school based care
Description: the research team will start an electronic data capture system linking school data and the clinical EMR (Cerner Power Chart) that will be implemented over the first year. Flow of data between schools and the hospital system will allow the children who have a regular source of care as well as those without a medical home to be treated with a unified asthma program by the school nurse and the hospital system.
Study NCT00025233 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bevacizumab
Description: Given IV
Study NCT00025233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT01363830 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Two-Week Post-Operative Restriction
Description: Surgeon recommends the patient restrict bending, lifting, and twisting for two-weeks following discectomy.
Study NCT01363830 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Six-Week Post-Operative Restriction
Description: Surgeon recommends patient restrict bending, lifting, and twisting for six-weeks following discectomy.
Study NCT03087357 — intervention group
Intervention type: OTHER
Intervention: SmartNIPT
Description: A novel, non-next generation sequencing (NGS) test that is designed to perform as well as conventional NGS screening while being simpler and less expensive.
Study NCT02926612 — intervention group
Intervention type: OTHER
Intervention: Next Generation Genomic Sequencing
Description: DNA and RNA are extracted from biospecimens, amplified, sequenced, and then compared to known microbe databases, allowing for quantitative identification of non-host organisms
Study NCT02058277 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: bosutinib or bosutinib + aprepitant
Description: Single dose of bosutinib (500 mg) or single dose of bosutinib (500 mg) and aprepitant (125 mg)
Study NCT00133211 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency ablation
Description: Pulmonary vein isolation
Study NCT00133211 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Description: Pulmonary vein isolation
Study NCT00651807 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: etonogestrel
Description: Lowest dose of Org 3236 per two days, lowest dose of Org 3236 per day, highest dose of Org 3236 per day for 8 weeks
Study NCT00651807 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Every day one tablet up to 8 weeks
Study NCT02345577 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stochastic whole body vibration (WBV) therapy - Physiotherapeutical intervention
Description: Physiotherapeutical intervention
Study NCT02345577 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Stochastic whole body vibration (WBV) therapy - Sham physiotherapeutical intervention
Description: Sham physiotherapeutical intervention
Study NCT02655809 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Fluoroscopic examination
Study NCT02410174 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy (SBRT)
Study NCT01712074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-05212377 (SAM-760)
Description: 30 mg QD of PF-05212377 (SAM-760)
Study NCT01712074 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo QD
Study NCT04619173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thoracic manipulation
Description: hot pack ,transcutaneous electrical nerve stimulation and manipulation along with stretching'
Study NCT04619173 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy Program
Description: hot pack ,transcutaneous electrical nerve stimulation and stretching
Study NCT00093223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel Nanoparticle Albumin Bound
Description: Single or duel doses of 35mg/m\^2 ABI-007, administered IV, administered after placement of denovo stent(s).
Study NCT00093223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel Nanoparticle Albumin Bound
Study NCT00093223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel Nanoparticle Albumin Bound
Description: 35mg/35 infusion time is 3.5 minutes
Study NCT01472835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Used for anxiolysis
Study NCT01472835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: Used for analgesia and as a sedative
Study NCT02403778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VESANOID
Description: All-trans retinoic acid (ATRA) is a vitamin A derivative that binds the retinoic acid receptor on MDSCs and differentiates immature monocytes into more mature dendritic cells (12). VESANOID is a standard treatment for patients with acute promyelocytic leukemia (APL).
Study NCT02403778 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ipilimumab
Description: Ipilimumab is current standard of care treatment for melanoma.
Study NCT02403778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Ipilimumab is current standard of care treatment for melanoma.
Study NCT00559351 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: transthoracic esophagectomy 2-field extended lymphadenectomy
Description: right thoracotomy, mobilization of the esophagus, mediastinal lymph node dissection, laparotomy, gastric tube formation, abdominal lymph node dissection, anastomosis in the neck
Study NCT00559351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemotherapy (cisplatin, 5-fluorouracil)
Description: 21-day combination systemic chemotherapy regimen consisted of a continuous infusion of cisplatin (20mg/m2/day) on days 1-5, 17-21 and 5-fluorouracil at 300mg/m2/day on days 1-21 followed by 3-phase transthoracic esophagectomy with 2-field extended lymphadenectomy after 3 week interval
Study NCT00559351 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoradiotherapy
Description: 21-day combination systemic chemotherapy regimen consisted of a continuous infusion of cisplatin (20mg/m2/day) on days 1-5, 17-21 and 5-fluorouracil at 300mg/m2/day on days 1-21 with concurrent external beam fractionated irradiation to a total dose of 30Gy (2Gy fractions on days 1-5, 8-12, 15-19) followed by 3-phase transthoracic esophagectomy with 2-field extended lymphadenectomy after 3 week interval
Study NCT03572114 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 3Tesla MRI
Description: 1. A previously validated multi-parameter mapping protocol sensitive to neuromelanin and iron content~2. Iron mapping and micro-bleed detection: QSM (quantitative susceptibility mapping), a fully flow-compensated, susceptibility-weighted gradient-echo sequence (5 minutes).~3. 1-mm isotropic anatomical MPRAGE (magnetization-prepared rapid gradient-echo)~4. conventional FLAIR sequence
Study NCT03572114 — intervention group
Intervention type: BEHAVIORAL
Intervention: Burke-Fahn-Marsden Dystonia Rating scale
Description: internationally standardized examination/quantification of dystonia
Study NCT03572114 — intervention group
Intervention type: BEHAVIORAL
Intervention: MDS-United Parkinsons Disease Rating Scale, Part III
Description: most recent, internationally standardized examination/quantification of bradykinesia / rigidity according to the Movement Disorder Society
Study NCT03572114 — intervention group
Intervention type: BEHAVIORAL
Intervention: Beck Depression Inventory
Description: internationally standardized examination to quantify traits of anxiety and depression
Study NCT03572114 — intervention group
Intervention type: BEHAVIORAL
Intervention: MoCA: Montreal Cognitive Assessment:
Description: internationally standardized examination to quantify cognition, frequently used in studies of dystonia and parkinsonism
Study NCT04063904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone
Description: One 200 mg pill (oral)
Study NCT04063904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol
Description: Two 400 mcg pills (sublingual)
Study NCT04455295 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transdermal Vagus Nerve Stimulation (tVNS)
Description: Mild non-invasive transdermal electrical stimulation at the ear (0.0-1.0 mA, 0.0-30.0 Hz). Used in previous studies with no unexpected adverse events. Stimulator not considered a FDA regulated device in previous studies.
Study NCT04455295 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Transdermal Vagus Nerve Stimulation (tVNS)
Description: Mild non-invasive transdermal electrical stimulation at the ear (0.0-1.0 mA, 0.0-30.0 Hz). Used in previous studies with no unexpected adverse events. Stimulator not considered a FDA regulated device in previous studies.
Study NCT05847335 — intervention group
Intervention type: BEHAVIORAL
Intervention: Survey work
Description: Childhood Trauma scale, Personality Beliefs questionnaire, Emotional Intelligence scale
Study NCT02903381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Intravenous, predetermined dosage, Days 1 and 15 during cycles 1-12 and
Study NCT02903381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Oral, predetermined dosage, Days 1-21 of cycle 1-12
Study NCT02903381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Oral, Days 1, 8, 15 of cycle 1-6
Study NCT02820103 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text+Visual BCT-based intervention
Description: Participants in the visual intervention group will receive usual care specified below plus a specifically developed Text + Visual BCT-based intervention, comprising 12 BCTs identified from SR and expert consensus study. An animated video, just under 8 minutes in length is hosted online in the Intervention Modelling Experiment. The animation contains 9 of the 12 BCTs and tells the 'delay stories' of three different characters. It was not possible to deliver all of the 12 BCTs comprehensively in the relatively passive media of the animation as some techniques require active participation from participants (e.g. action planning). Thus, n=7 BCTs (1 2 Problem-solving; 1 4 Action planning; 5 2 Salience of consequences; 7 1 Prompts/cues; 9 3 Comparative imagining of future outcomes; 15 2 Mental rehearsal of successful performance) are also delivered via short web-based exercises which follow the animation.
Study NCT02820103 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text-only BCT intervention
Description: Participants in the text-only BCT-based intervention group will receive the usual care specified above plus a text-only BCT-based intervention. This was developed in the same way as the text + visual BCT-based intervention but does not include the visual elements (i.e. animation). Instead, the voiceover from the animated film is displayed in text on screen and narrated in audio. The BCTs which require active engagement are delivered via identical web-based exercises as the text + visual BCT-based intervention.
Study NCT02820103 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Leaflet information (control)
Description: Participants in the control group will receive information that is currently used routinely in the NHS site to inform patients with ACS what to do if they experience symptoms after discharge.
Study NCT02820103 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Leaflet information (control)
Description: Participants in the control group will receive information that is currently used routinely in the NHS site to inform patients with ACS what to do if they experience symptoms after discharge.
Study NCT03109925 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DC Lumi Bead, BTG
Description: Embolic agent which is radio-opaque
Study NCT00573820 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Far Infrared Radiation
Description: Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each treatment session.
Study NCT02261142 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multifocal TENS garment (Mollii®)
Description: Multifocal transcutaneous electrical stimulation incorporated into a whole-body garment in combination with training
Study NCT02261142 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Multifocal TENS garment (Mollii®)
Description: Multifocal transcutaneous electrical stimulation incorporated into a whole-body garment in combination with training
Study NCT01062295 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Siesta-System
Study NCT01062295 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard headrest
Study NCT04595812 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Misoprostol 200mcg Tab vaginal
Description: 2 tablets vaginally 1 hour before surgery
Study NCT04595812 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: 30 IU oxytocin in 500 ml normal saline at a rate of 120 ml/h
Study NCT04595812 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbetocin
Description: 100 μg IV Carbetocin (1ml) in 5 ml saline over 1 minute
Study NCT04595812 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pericervical hemostatic tourniquet
Description: a Foley catheter size 18, which will be firmly tied at the level of the cervico-isthmic junction of the uterus before the uterine incision,The time of tourniquet administration will be recorded, and will be released not later than 45 minutes after its application. For those requiring multiple applications, the tourniquet will be reapplied after a period of at least 15 minutes.
Study NCT03927755 — intervention group
Intervention type: OTHER
Intervention: Education
Description: Physicians will undergo training on how to rapidly obtain appropriate images.
Study NCT01529216 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DIAMOND System
Description: Electrical stimulation to the fundus
Study NCT01529216 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: DIAMOND System
Description: Electrical stimulation to the fundus
Study NCT02256774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combivir®
Study NCT02256774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Study NCT00775307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PAZOPANIB
Description: 400 mg/day (24 weeks)
Study NCT00775307 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 400 mg/day (24 weeks)
Study NCT00676039 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Venlafaxine
Description: NOVO-Venlafaxine XR 75 mg (NOVOPHARM, Generic)
Study NCT02137681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab was given intravenously at a dose of 375mg/m(2) weekly for 2 consecutive weeks (Day 1, 8) in 2 cycles arm; or 4 consecutive weeks (Day 1, 8, 15, 22) in standard 4 cycles arm
Study NCT02137681 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: Rituximab was given intravenously at a dose of 375mg/m(2) weekly for 2 consecutive weeks (Day 1, 8) in 2 cycles arm; or 4 consecutive weeks (Day 1, 8, 15, 22) in standard 4 cycles arm